Related Experiment Video
Updated: May 23, 2026
10:04
Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models
Published on: March 13, 2018
Nuclear IRS-1 and cancer
Krzysztof Reiss1, Luis Del Valle, Adam Lassak
1Neurological Cancer Research, Stanley S. Scott Cancer Center, School of Medicine, LSU Health Sciences Center, New Orleans, LA 70112, USA. kreiss@lsuhsc.edu
Journal of Cellular Physiology
|March 29, 2012
Summary
Insulin receptor substrate-1 (IRS-1) is found in the nucleus, not just the cytoplasm. Nuclear IRS-1 may promote tumor growth by affecting DNA repair, gene activity, and cell proliferation.
Area of Science:
- Molecular Biology
- Cellular Biology
- Oncology
Background:
- Insulin receptor substrates (IRS) are key signaling proteins for insulin and IGF-1 receptors.
- IRS-1, a primary member, is known for its role in cell metabolism and growth.
- Emerging evidence suggests IRS-1 may also contribute to malignant transformation.
Purpose of the Study:
- To investigate the role of nuclear IRS-1 in cellular transformation and tumor development.
- To explore the mechanisms by which nuclear IRS-1 influences DNA repair, transcription, and cell growth.
- To consolidate evidence for nuclear IRS-1 presence in various cancer types.
Main Methods:
- Review of existing literature and previous experimental findings.
- Analysis of IRS-1 localization in various cell types and clinical samples.
- Discussion of IRS-1's interaction with oncogenic proteins and receptors.
Main Results:
- Nuclear localization of IRS-1 has been confirmed in multiple cell types, including medulloblastoma, breast cancer, and immortalized fibroblasts.
- Nuclear IRS-1 has been detected in association with viral oncoproteins (JCV T-antigen, SV40 T-antigen) and hormone receptors (ERα, ERβ).
- IRS-1's nuclear function is implicated in modulating DNA repair fidelity, transcriptional activity, and cell growth.
Conclusions:
- Nuclear IRS-1 is a significant factor in cellular transformation and tumor progression.
- The presence and function of nuclear IRS-1 offer potential therapeutic targets for cancer treatment.
- Further research is warranted to fully elucidate the oncogenic mechanisms involving nuclear IRS-1.
Related Concept Videos
01:31Regulation of the Unfolded Protein Response
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
02:26NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:31Transducer Mechanism: Nuclear Receptors
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...